Anticorps Recombinant de lapin anti-ICOS/CD278

ICOS/CD278 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

FC

Conjugaison

Biotin

CloneNo.

242639C3

N° de cat : Biotin-FcA98341

Synonymes

Activation-inducible lymphocyte immunomediatory molecule, Ailim, CCLP, CD278, CD28 and CTLA-4-like protein



Applications testées

Résultats positifs en cytométrieAnti-CD3/CD28 treated BALB/c spleen cells

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

Biotin-FcA98341 cible ICOS/CD278 dans les applications de FC et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène ICOS/CD278 Protéine recombinante Eg3198
Nom complet inducible T-cell co-stimulator
Masse moléculaire calculée23kDa
Numéro d’acquisition GenBankNM_017480.2
Symbole du gène Icos
Identification du gène (NCBI) 54167
Conjugaison Biotin
Excitation/Emission maxima wavelengths-
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

Inducible T cell co-stimulator (ICOS) is related to the CD28 superfamily and is highly expressed on activated T cells as well as regulatory T cells and is crucial for the survival and function of T cells, Th2 cell differentiation, and lung inflammatory responses. Binding ICOS to ICOS-ligand (ICOS-L) activates a cascade of intracellular signaling molecules that prevent apoptosis and lead to the production of cytokines such as IL-4 and IL-13.

Protocole

Product Specific Protocols
FC protocol for Biotin ICOS/CD278 antibody Biotin-FcA98341Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}